Abstract
Rationale and Objectives Physical inactivity is more common in older adults, is associated with social isolation and loneliness, and contributes to increased morbidity and mortality. We examined the effect of social restrictions, implemented to reduce transmission of COVID-19 in the UK (lockdown), on physical activity (PA) levels of older adults, and the demographic, lifestyle and social predictors of this change.
Methods Cognitively healthy adults aged over 50 years from the Cognitive Health in Ageing Register for Investigational and Observational Trials (CHARIOT) cohort were invited to complete a survey of demographic and lifestyle details, social factors, mood, and frailty. Retrospective (pre-lockdown) and current (post-lockdown) PA were captured by the International Physical Activity Questionnaire (IPAQ) short form.
Results 6,219 adults aged 50 to 92 years completed the survey during the period of April - July 2020. Mean PA significantly reduced following lockdown, from 3,519 Metabolic Equivalent of Task (MET) minutes/week to 3,185 MET minutes/week (p<0.001). Multivariable linear regression models showed that: those who were divorced or single (240 [95% CI: 120, 360] MET minutes/week less); living alone (277 [95% CI: 152, 402] MET minutes/week less); and reported feeling lonely often (306 [95% CI: 60, 552] MET minutes/week less); were doing less PA after lockdown than those married, co-habiting and not reporting loneliness, respectively.
Conclusions and Implications Markers of social isolation and loneliness were associated with a reduction in PA following lockdown in the UK. Interventions to improve PA in older adults should take account of social and community factors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Work towards this article was in part supported by the National Institute for Health Research Applied Research Collaboration Northwest London and Imperial Biomedical Research Centre (BRC).DS and TB are supported by the National Institute of Health Research Academic Clinical Fellowships. The views expressed in this publication are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Imperial College Research Ethics Committee approval: 20IC5942, dated 22/04/2020
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Contributorship and the guarantor DS, TB and CR conceived the paper, developed the survey materials, carried out the analysis, wrote the paper equally as joint lead authors and are the guarantors. All authors developed the survey, carried out analysis and contributed to the development and editing of the paper.
How patients were involved in the creation of this article Older adult volunteers (60-80 years of age) from various social and cultural backgrounds provided feedback on the survey content. This feedback was incorporated into the survey design
Conflicts of Interest We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: none
Licence The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, a worldwide licence (http://www.bmj.com/sites/default/files/BMJ%20Author%20Licence%20March%202013.doc) to the Publishers and its licensees in perpetuity, in all forms, formats and media (whether known now or created in the future), to i) publish, reproduce, distribute, display and store the Contribution, ii) translate the Contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or, abstracts of the Contribution and convert or allow conversion into any format including without limitation audio, iii) create any other derivative work(s) based in whole or part on the on the Contribution, iv) to exploit all subsidiary rights to exploit all subsidiary rights that currently exist or as may exist in the future in the Contribution, v) the inclusion of electronic links from the Contribution to third party material where-ever it may be located; and, vi) licence any third party to do any or all of the above.
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.